-
-
-
-
-
-
-
Biomea Fusion partners with University of Leicester for obesity study
-
-
-
-
-
-
-
Biomea Fusion advances diabetes drug trials in 2026
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)
-
-
-
-
-
-
-
Biomea Fusion Inc. (BMEA) PT Raised to $19 at Piper Sandler
-
-
-
-
-
-
-
Biomea Fusion (BMEA) Gains 11%, Analysts Positive After FDA Lifts Clinical Holds on BMF-219 in Type 2 and Type 1 Diabetes Trials
-
-
-
-
-
-
-
Biomea Fusion Inc. (BMEA) PT Lowered to $15 at H.C. Wainwright
458,134 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

